Management of hyperkalemia in hospitalized patients

American Journal of the Medical Sciences

Volumn 347, Issue 2, 2014, Pages 93-100

  Fordjour, Kristy N ^a   Walton, Ted ^b   Doran, John J ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY HEALTH SYSTEM   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Electrocardiography; Hyperkalemia; Kidney failure; Sodium polystyrene sulfonate

Indexed keywords

BICARBONATE; CALCIUM; CREATININE; INSULIN; POLYSTYRENESULFONATE SODIUM; POTASSIUM; SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DIALYSIS; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERKALEMIA; INSULIN TREATMENT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; POTASSIUM BLOOD LEVEL; PR INTERVAL; RETROSPECTIVE STUDY; T WAVE; TERTIARY CARE CENTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; CALCIUM; CATION EXCHANGE RESINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERKALEMIA; INSULIN; KIDNEY DISEASES; MALE; MIDDLE AGED; POLYSTYRENES; RENAL DIALYSIS; SODIUM BICARBONATE; YOUNG ADULT;

EID: 84894059339     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318279b105     Document Type: Article

References (31)

1. Paice B, Gray JM, McBride D, et al. Hyperkalaemia in patients in hospital. Br Med J (Clin Res Ed) 1983;286:1189-92.
2. Moore ML, Bailey RR. Hyperkalaemia in patients in hospital. N Z Med J 1989;102:557-8.
3. Borra S, Shaker R, Kleinfeld M. Hyperkalemia in an adult hospitalized population. Mt Sinai J Med 1988;55:226-9.
4. Shemer J, Modan M, Ezra D, et al. Incidence of hyperkalemia in hospitalized patients. Isr J Med Sci 1983;19:659-61.
5. Acker CG, Johnson JP, Palevsky PM, et al. Hyperkalemia in hospitalized patients: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917-24.
6. Mikrut M, Brockmiller-Sell H. Sodium polystyrene sulfonate dosing guidelines for the treatment of hyperkalemia. Hosp Pharm 2004;39:765-71.
7. Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987;147:867-9.
8. Sterns RH, Rohas M, Bernstein P, et al. Ion-exchange resins for the treatment of hyperkalemia: Are they safe and effective? J Am Soc Nephrol 2010;21:733-5.
9. Lillemoe KD, Romolo JL, Hamilton SR, et al. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: Clinical and experimental support for the hypothesis. Surgery 1987;101:267-72.
10. Thomas A, James BR, Landsberg D. Colonic necrosis due to oral kayexalate in a critically-ill patient. Am J Med Sci 2009;337:305-6.
11. Kayexelate (Sodium Polystyrene Sulfonate, USP) [Package Insert]. Bridgewater, NJ: Sanofi-Aventis US LLC; 2010.
12. Hiatt N, Sheinkopf JA. Treatment of experimental hyperkalemia with large doses of insulin. Surg Gynecol Obstet 1971;133:833-6.
13. Rolf-smith S, Kendall MJ. Inhaled bronchodilators and hypokalemia. Lancet 1983;2:218.
14. Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 1992;41:369-74.
15. Palmer RA, Price JD, Eden J. The treatment of hyperkalemia by carboxylic acid resins in the upper and lower gastrointestinal tract. Can Med Assoc J 1959;80:432-5.
16. Schwartz KC, Lubash GD, Rubin AL, et al. Severe acidosis and hyperpotassemia treated with sodium bicarbonate infusion. Circulation 1959;19:215-20.
17. Wargo KA, Banta WM. A comprehensive review of the loop diuretics: Should furosemide be first line? Ann Pharmacother 2009;43:1836-47.
18. Neville A, Palmer JB, Gaddie J, et al. Metabolic effects of salbutamol: Comparison of aerosol and intravenous administration. Br Med J 1977; 1:413-4.
19. Bellet S. The electrocardiogram in electrolyte imbalance. AMA Arch Intern Med 1955;96:618-38.
20. Braun HA, Surawicz B, Bellet S. T waves in hyperpotassemia; their differentiation simulating T waves in other conditions. Am J Med Sci 1955;230:147-56.
21. Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol 2008;3:324-30.
22. Parham WA, Mehdirad AA, Biermann KM, et al. Hyperkalemia revisited. Tex Heart Inst J 2006;33:40-7.
23. Iqbal Z, Friedman EA. Preferred therapy of hyperkalemia in renal insufficiency: Survey of nephrology training program directors. N Engl J Med 1989;320:60-1.
24. Badve SV, Roberts MA, Hawley CM, et al. Effects of beta-Adrenergic antagonists in patients with chronic kidney disease. J Am Coll Cardiol 2011;58:1152-61.
25. Gruy-Kaprl C, Emmett M, Santa Ana CA, et al. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end stage renal disease. J Am Soc Nephrol 1998;9:1924-30.
26. Alvestrand A, Wahren J, Smith D, et al. Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol 1984; 246:E174-80.
27. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterol. Am J Kidney Dis 1996;28:508-14.
28. Blumberg A, Weidmann P, Shaw S, et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988;85:507-12.
29. Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989;110:426-9.
30. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990;38:869-72.
31. Albuterol Sulfate Inhalation Solution, 0.083% [Package Insert]. Orlando, FL: Nephron Pharmaceuticals; 2005.